Autoimmune primary ovarian insufficiency

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 427-430

  Silva, C A ^a   Yamakami, L Y S ^a   Aikawa, N E ^a   Araujo, D B ^a,b   Carvalho, J F ^c   Bonfa E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c Faculdade de Medicina da Bahia   (Brazil)

Author keywords

Anti M llerian hormone; Autoimmune oophoritis; Autoimmune primary ovarian insufficiency; Fertility; Ovarian reserve; Premature ovarian failure

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CORTICOSTEROID; ESTROGEN; FOLLITROPIN;

AMENORRHEA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL FEATURE; CONCEPTION; CORTICOSTEROID THERAPY; DYSPAREUNIA; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INFERTILITY; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LYMPHOCYTIC INFILTRATION; MENSTRUATION; OOCYTE; OVARIAN RESERVE; OVARY INFLAMMATION; PATHOGENESIS; PRACTICE GUIDELINE; PREGNANCY; PREMATURE OVARIAN FAILURE; REVIEW; T LYMPHOCYTE; THECA CELL; VAGINA ATROPHY;

ANTI-MÜLLERIAN HORMONE; AUTOIMMUNE OOPHORITIS; AUTOIMMUNE PRIMARY OVARIAN INSUFFICIENCY; FERTILITY; OVARIAN RESERVE; PREMATURE OVARIAN FAILURE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; FEMALE; HUMANS; INFERTILITY; PRIMARY OVARIAN INSUFFICIENCY; T-LYMPHOCYTES;

EID: 84896316963     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.003     Document Type: Review

References (37)

1. Silva C.A., Cocuzza M., Borba E.F., Bonfá E. Cutting-edge issues in autoimmune orchitis. Clin Rev Allergy Immunol 2012, 42:256-263.
2. Practice Committee of the American Society for Reproductive Medicine Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2012, 98:1407-1415.
3. Broekmans F.J., Soules M.R., Fauser B.C. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009, 30:465-493.
4. Silva C.A., Leal M.M., Leone C., Simone V.P., Takiuti A.D., Saito M.I., et al. Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 2002, 11:419-425.
5. Silva C.A., Brunner H.I. Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 2007, 16:593-599.
6. Medeiros P., Febrônio M., Bonfá E., Borba E., Takiuti A., Silva C.A. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 2009, 18:38-43.
7. Aikawa N.E., Sallum A.M., Leal M.M., Bonfá E., Pereira R.M., Silva C.A. Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol 2010, 28:571-575.
8. Silva C.A., Bonfa E., Ostensen M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res (Hoboken) 2010, 62:1682-1690.
9. Aikawa N.E., Sallum A.M., Pereira R.M., Suzuki L., Viana V.S., Bonfa E., et al. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol 2012, 30:445-449.
10. Pereira R.M., de Carvalho J.F., de Medeiros A.C., Silva C.A., Capelozzi V., Bonfá E. Ovarian necrotizing vasculitis in a patient with lupus. Lupus 2009, 18:1313-1315.
11. Pasoto S.G., Viana V.S., Mendonca B.B., Yoshinari N.H., Bonfa E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus?. J Rheumatol 1999, 26:1087-1093.
12. Ostensen M., Brucato A., Carp H., Chambers C., Dolhain R.J., Doria A., et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 2011, 50:657-664.
13. Cabral de Sousa D., das Chagas Medeiros M.M., Trindade Viana V.S., Salani Mota R.M. Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto's thyroiditis. Lupus 2005, 14:618-624.
14. La Marca A., Brozzetti A., Sighinolfi G., Marzotti S., Volpe A., Falorni A. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol 2010, 22:277-282.
15. Welt C.K. Autoimmune oophoritis in the adolescent. Ann N Y Acad Sci 2008, 1135:118-122.
16. Visser J.A., Schipper I., Laven J.S., Themmen A.P. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 2012, 8:331-341.
17. Khole V. Does ovarian autoimmunity play a role in the pathophysiology of premature ovarian insufficiency?. J Midlife Health 2010, 1:9-13.
18. Carp H.J., Selmi C., Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012, 38:J266-J274.
19. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997, 18:107-134.
20. Shelling A.N. Premature ovarian failure. Reproduction 2010, 140:633-641.
21. Haller-Kikkatalo K., Salumets A., Uibo R. Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone. Clin Dev Immunol 2012, 2012:1-15. [762541]. 10.1155/2012/762541.
22. Carneiro-Sampaio M., Moraes-Vasconcelos D., Kokron C.M., Jacob C.M., Toledo-Barros M., Dorna M.B., et al. Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol 2013, 33:716-724.
23. Betterle C., Volpato M. Adrenal and ovarian autoimmunity. Eur J Endocrinol 1998, 138:16-25.
24. Chang Y.S., Lai C.C., Chen W.S., Wang S.H., Chou C.T., Tsai C.Y. Protein-losing enteropathy and premature ovarian failure in a young woman with systemic lupus erythematosus. Lupus 2012, 21:1237-1239.
25. Euthymiopoulou K., Aletras A.J., Ravazoula P., Niarakis A., Daoussis D., Antonopoulos I., et al. Antiovarian antibodies in primary Sjogren's syndrome. Rheumatol Int 2007, 27:1149-1155.
26. Kalantaridou S.N., Braddock D.T., Patronas N.J., Nelson L.M. Treatment of autoimmune premature ovarian failure. Hum Reprod 1999, 14:1777-1782.
27. Conway G.S. Premature ovarian failure. Br Med Bull 2000, 56:643-649.
28. Tsigkou A., Luisi S., De Leo V., Patton L., Gambineri A., Reis F.M., et al. High serum concentration of total inhibin in polycystic ovary syndrome. Fertil Steril 2008, 90:1859-1863.
29. Altuntas C.Z., Johnson J.M., Tuohy V.K. Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J Immunol 2006, 177:1988-1996.
30. Dal Pra C., Chen S., Furmaniak J., Smith B.R., Pedini B., Moscon A., et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. Eur J Endocrinol 2003, 148:565-570.
31. Goswami D., Conway G.S. Premature ovarian failure. Hum Reprod Update 2005, 11:391-410.
32. Calongos G., Hasegawa A., Komori S., Koyama K. Harmful effects of anti-zona pellucida antibodies in folliculogenesis, oogenesis, and fertilization. J Reprod Immunol 2009, 79:148-155.
33. Jin M., Yu Y., Huang H. An update on primary ovarian insufficiency. Sci China Life Sci 2012, 55:677-686.
34. Reindollar R.H. Turner syndrome: contemporary thoughts and reproductive issues. Semin Reprod Med 2011, 29:342-352.
35. Sammaritano L.R. Menopause in patients with autoimmune diseases. Autoimmun Rev 2012, 11:A430-A436.
36. Bakalov V.K., Gutin L., Cheng C.M., Zhou J., Sheth P., Shah K., et al. Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun 2012, 38:315-321.
37. Carp H.J., Selmi C., Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun 2012, 38:J266-J274.